A review of nanoparticle drug delivery systems responsive to endogenous breast cancer microenvironment

2021 ◽  
Vol 166 ◽  
pp. 30-43
Author(s):  
Tengteng Zou ◽  
Wenping Lu ◽  
Yaroslav Mezhuev ◽  
Meng Lan ◽  
Lihong Li ◽  
...  
2014 ◽  
Vol 3 (2) ◽  
pp. 105-118 ◽  
Author(s):  
Pedro Martins ◽  
Daniela Rosa ◽  
Alexandra Fernandes ◽  
Pedro V. Baptista

Author(s):  
Sedighe Forouhari ◽  
Zahra Beygi ◽  
Zahra Mansoori ◽  
Sara Hajsharifi ◽  
Fatemeh Heshmatnia ◽  
...  

2015 ◽  
Vol 160 (1) ◽  
pp. 24-35 ◽  
Author(s):  
James D. Fisher ◽  
Abhinav P. Acharya ◽  
Steven R. Little

2020 ◽  
Vol Volume 13 ◽  
pp. 23-36 ◽  
Author(s):  
Nasrul Wathoni ◽  
Agus Rusdin ◽  
Keiichi Motoyama ◽  
I Made Joni ◽  
Ronny Lesmana ◽  
...  

2020 ◽  
Vol 56 ◽  
pp. 101505 ◽  
Author(s):  
Umme Hani ◽  
Mohamed Rahamathulla ◽  
Riyaz Ali Osmani ◽  
Honnavalli Yogish Kumar ◽  
Deeparani Urolagin ◽  
...  

Cancers ◽  
2019 ◽  
Vol 11 (5) ◽  
pp. 640 ◽  
Author(s):  
Jihye Yoo ◽  
Changhee Park ◽  
Gawon Yi ◽  
Donghyun Lee ◽  
Heebeom Koo

Targeting nanoparticle (NP) carriers to sites of disease is critical for their successful use as drug delivery systems. Along with optimization of physicochemical properties, researchers have focused on surface modification of NPs with biological ligands. Such ligands can bind specific receptors on the surface of target cells. Furthermore, biological ligands can facilitate uptake of modified NPs, which is referred to as ‘active targeting’ of NPs. In this review, we discuss recent applications of biological ligands including proteins, polysaccharides, aptamers, peptides, and small molecules for NP-mediated drug delivery. We prioritized studies that have demonstrated targeting in animals over in vitro studies. We expect that this review will assist biomedical researchers working with NPs for drug delivery and imaging.


Sign in / Sign up

Export Citation Format

Share Document